• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Lose Weight, Save Medicare $35 Billion

Article

A 10% weight loss in patients age 60 to 64 may be able to provide Medicare savings of $8 billion over 10 years and $35 billion over their lifetime, according to Kenneth E. Thorpe, PhD.

A 10% weight loss in patients age 60 to 64 may be able to provide Medicare savings of $8 billion over 10 years and $35 billion over their lifetime, according to Kenneth E. Thorpe, PhD. Thorpe is a professor and chair of health policy and management at the Emory Rollins School of Public Health. He also serves as executive director of the partnership to fight chronic diseases and as a consultant to biopharmaceutical company, VIVUS.

He says many of the government's current approaches to weight loss are not addressing obesity, which is responsible for the rising rates of diabetes, hypertension and dyslipdemia. 

“Weight loss generates lower spending,” Thorpe says. “We spend 40% more on healthcare for obese people than for normal-weight people.”

He says if the Medicare program made evidence-based lifestyle modification programs-such as the YMCA’s Diabetes Prevention Program via UnitedHealthcare-available to everyone at age 60, it would generate $7 billion in savings over the next decade.

“The payers that don't have evidence-based workplace wellness programs are missing big opportunity,” he says. “We have a decade of data showing that it works.”

He is also hopeful about a range of investigational weight-loss drugs still pending FDA approval he says can help achieve a 10% to 15% reduction in weight.

Go back to the Managed Healthcare Executive eNews newsletter.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.